Adline Chem Lab Ltd.
| BSE: 524604 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE276T01018 |
| BSE 00:00 | 29 Apr | 8.34 |
0 (0.00%) |
OPEN
8.34 |
HIGH
8.34 |
LOW
8.34 |
| NSE 05:30 | 01 Jan | Adline Chem Lab Ltd |
| OPEN | 8.34 |
| PREVIOUS CLOSE | 8.34 |
| VOLUME | 100 |
| 52-Week high | 11.44 |
| 52-Week low | 4.79 |
| P/E | |
| Mkt Cap.(Rs cr) | 5 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Adline Chem Lab Ltd. (ADLINECHEMLAB) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 520.10 | -18.50 | -3.43 | 15823.68 |
| Cipla | 976.50 | 6.00 | 0.62 | 13900.58 |
| Dr Reddy's Labs | 4327.65 | -23.45 | -0.54 | 13349.10 |
| Sun Pharma.Inds. | 908.95 | -1.25 | -0.14 | 12803.21 |
| Lupin | 589.80 | -11.35 | -1.89 | 11055.93 |
| Apollo Hospitals | 3590.30 | -42.10 | -1.16 | 9153.00 |
| Zydus Lifesci. | 365.50 | -2.65 | -0.72 | 7790.40 |
| Glenmark Pharma. | 389.00 | -5.55 | -1.41 | 7567.93 |
| Alkem Lab | 2963.85 | 31.45 | 1.07 | 7219.68 |
| Divi's Lab. | 3623.85 | -38.20 | -1.04 | 6798.61 |
| Torrent Pharma. | 2629.85 | 37.35 | 1.44 | 6450.83 |
| Ipca Labs. | 935.95 | -19.65 | -2.06 | 5114.11 |
| Alembic Pharma | 740.50 | -15.85 | -2.10 | 5051.44 |
| Laurus Labs | 554.05 | -13.10 | -2.31 | 4768.72 |
| Abbott India | 18088.15 | -103.65 | -0.57 | 4310.02 |
| Gland Pharma | 2870.75 | -0.90 | -0.03 | 3462.88 |
| Glaxosmi. Pharma | 1529.50 | -24.25 | -1.56 | 3193.74 |
| Granules India | 266.45 | -14.30 | -5.09 | 3134.98 |
| Sanofi India | 6546.45 | -41.35 | -0.63 | 2956.60 |
| Ajanta Pharma | 1701.00 | 1.70 | 0.10 | 2718.59 |
Quick Links for Adline Chem Lab:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
